TORONTO, May 17, 2018 /PRNewswire/ - GeneNews Ltd ("Genenews" or the "Company") (TSX:GEN) today announced that it is partnering with AIM Laboratories ("AIM"), a privately held diagnostic laboratory in St Louis, Missouri to offer its tests to AIM's client base. GeneNews will reciprocate by offering AIM's tests to the Innovative Diagnostic Laboratory client base.
"Combining forces and capitalizing on each company's geographic strengths will help both parties expand rapidly throughout the U.S. Market," commented James R. Howard-Tripp, GeneNews' Chairman and CEO. "In addition, this collaboration will give both companies the opportunity to expand their test menus in order to provide additional benefits to new and existing practices and healthcare systems."
"IDL and AIM already work together in servicing some of IDL's clients in the Midwest," said Sonny Naqvi, AIM's CEO. "This new agreement will allow us to expand operations together, particularly in the fast growing areas of high-risk populations and telemedicine."
The collaboration will begin immediately.
About AIM Laboratories
AIM Laboratories is a premiere, community-based clinical laboratory strategically located in the center of the U.S., in St. Louis Missouri. AIM Laboratories was established by a unique group of dedicated scientists and business executives to provide the healthcare community with the highest level of localized science, service and support. While our advanced facility and scientific staff are capable of running 1000 tests an hour, each of our clients receive superior, prompt and individualized service.
This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events, including the restructuring of its business. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.